These results thus suggest a plausible biological pathway through which low SES, by methylation of SLC6A4, could attenuate expression of the serotonin transporter encoded by this gene, leading to increases in both amygdala reactivity and risk of depression. This evidence concerns the gene SLC6A4 and depressive symptom measurement.